Trials / Completed
CompletedNCT04907474
Evaluation of Pupil Dilation Speed With the MAP Dispenser
A Study Evaluating Pupil Dilation Speed With the Micro-Array Print (MAP) Dispenser Comparing 2 Dosing Regimens of Tropicamide-Phenylephrine Fixed Combination Ophthalmic Solution
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 61 (actual)
- Sponsor
- Eyenovia Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
1 mist or 2 mists of the study drug will be administered to both eyes according to a pre-specified randomization plan to determine the effect on pupil dilation
Detailed description
After screening, eligible subjects will be scheduled for 2 treatment visits where either 1 mist or 2 mists of the study drug will be administered to both eyes according to a pre-specified randomization plan. Safety evaluations and efficacy measurements will be performed at specified time intervals thereafter. Pupil dilation for each treatment will be compared at each time interval.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | tropicamide-phenylephrine fixed combination ophthalmic solution | Tropicamide-phenylephrine fixed combination ophthalmic solution is a tropical drug solution for mydriasis |
Timeline
- Start date
- 2021-05-24
- Primary completion
- 2021-06-03
- Completion
- 2021-06-03
- First posted
- 2021-05-28
- Last updated
- 2025-01-09
- Results posted
- 2025-01-09
Locations
1 site across 1 country: Mexico
Source: ClinicalTrials.gov record NCT04907474. Inclusion in this directory is not an endorsement.